Sonnet BioTherapeutics, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • CEO Corner
  • Technology
    • Overview
    • Platform
    • Publications
  • Pipeline
    • Overview
    • SON-1010
    • SON-1210
    • SON-080
    • Clinical Trials
  • Partnering
  • News & Media
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact

Press Releases

News & Media

News & Media

  • Press Releases
  • Presentations
  • Events
Feb 01, 2021 6:30am EST

Sonnet BioTherapeutics Completes Successful Repeat Dose Study of SON-1010 in Non-Human Primates

Jan 25, 2021 6:30am EST

Sonnet BioTherapeutics Announces the Successful Completion of a Non-human Primate Toxicology Study of SON-080

Dec 17, 2020 6:30am EST

Sonnet BioTherapeutics Provides Fiscal Year 2020 Business and Earnings Update

Nov 30, 2020 8:30am EST

Sonnet BioTherapeutics Announces the Completion of a Successful Non-Human Primate Study of SON-1010

Sep 01, 2020 8:30am EDT

Sonnet Announces New Preclinical Data for SON-1010 (Interleukin 12-F(H)AB)

Aug 25, 2020 7:30am EDT

Sonnet BioTherapeutics Receives $10.5 Million from Exercise of Series A Warrants

Aug 14, 2020 7:30am EDT

Sonnet BioTherapeutics Provides Fiscal Year Third Quarter Business and Earnings Update

Aug 04, 2020 7:35am EDT

Sonnet BioTherapeutics Announces At-The-Market Warrant Repricing and Exchange Resulting in Expected Gross Proceeds to the Company of up to $10.5 Million

Aug 04, 2020 7:30am EDT

Sonnet BioTherapeutics Signs Letter of Intent for Potential Licensing of Neuropathies Asset to New Life Therapeutics

Jul 20, 2020 7:30am EDT

Sonnet Biotherapeutics Announces Positive Preclinical Results from an Initial Efficacy Study Exploring the Combination of Granulocyte-Macrophage Colony-Stimulating Factor with Interleukins 18 and 12

RSS
  • Prev
    • 1...
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    Next
    © 2025 Sonnet BioTherapeutics, Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap